← FDA Drug Approvals (Drugs@FDA)

SODIUM BICARBONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EXELA PHARMA · Approved 2019-06-20

Drug application

FDA Application #

ANDA211091

Application type

Abbreviated New Drug Application (Generic)

Brand name

SODIUM BICARBONATE

Generic name

SODIUM BICARBONATE

Active ingredients

SODIUM BICARBONATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

EXELA PHARMA

Manufacturer

Civica

First approval

2019-06-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown